Deferasirox prevents progression of non-alcoholic steatohepatitis in a mouse model with inhibition of heaptic fibrosis and hepatocellular ballooning

被引：0
|
作者：
Korenaga, Masaaki [1 ]
Korenaga, Keiko [1 ]
Mizokami, Masashi [1 ]
Kanto, Tatsuya [1 ]
机构：
[1] Natl Ctr Global Hlth & Med NCGM Kohnodai, Res Ctr Hepstitis & Immunol, Ichikawa, Japan
来源：
HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1583
引用
收藏
页码：785A / 786A
页数：2
相关论文
共 50 条
  • [1] Lansoprazole prevents the progression of liver fibrosis in non-alcoholic steatohepatitis model rats
    Nishi, Toshio
    Yamamoto, Yuta
    Yamagishi, Naoko
    Iguchi, Mikitaka
    Tamai, Hideyuki
    Ito, Takao
    Tsuruo, Yoshihiro
    Ichinose, Masao
    Kitano, Masayuki
    Ueyama, Takashi
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2018, 70 (03) : 383 - 392
  • [2] Periostin antisense oligonucleotide prevents hepatic steatosis and fibrosis in a mouse model of non-alcoholic steatohepatitis
    Kobayashi, Tomoki
    Kanno, Keishi
    Nguyen, Phuong Thao
    Sugiyama, Akiko
    Kawahara, Akihiro
    Otani, Yuichiro
    Kishikawa, Nobusuke
    Ito, Masanori
    Tazuma, Susumu
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 (12) : 2140 - 2150
  • [3] A mouse model for Non-alcoholic Steatohepatitis
    Sundaresan, Sinju
    Vijayagopal, Parakat
    Mills, Nathaniel
    Imrhan, Victorine
    Prasad, Chandan
    FASEB JOURNAL, 2010, 24
  • [4] REDUCTION OF ENDOPLASMIC RETICULUM STRESS PREVENTS HEPATIC FIBROSIS AND TUMORIGENESIS IN MOUSE MODEL OF NON-ALCOHOLIC STEATOHEPATITIS
    Kon, K.
    Ikejima, K.
    Uchiyama, A.
    Yamashina, S.
    Watanabe, S.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2012, 36 : 54A - 54A
  • [5] Natural Progression of Non-Alcoholic Steatohepatitis to Hepatocellular Carcinoma
    Ramai, Daryl
    Tai, Waqqas
    Rivera, Michelle
    Facciorusso, Antonio
    Tartaglia, Nicola
    Pacilli, Mario
    Ambrosi, Antonio
    Cotsoglou, Christian
    Sacco, Rodolfo
    BIOMEDICINES, 2021, 9 (02) : 1 - 17
  • [6] L-Carnitine Prevents Progression of Non-Alcoholic Steatohepatitis in a Mouse Model with Upregulation of Mitochondrial Pathway
    Ishikawa, Hisashi
    Takaki, Akinobu
    Tsuzaki, Ryuichiro
    Yasunaka, Tetsuya
    Koike, Kazuko
    Shimomura, Yasuyuki
    Seki, Hiroyuki
    Matsushita, Hiroshi
    Miyake, Yasuhiro
    Ikeda, Fusao
    Shiraha, Hidenori
    Nouso, Kazuhiro
    Yamamoto, Kazuhide
    PLOS ONE, 2014, 9 (07):
  • [7] L-carnitine prevents progression of non-alcoholic steatohepatitis in a mouse model with upregulation of mitochondrial pathway
    Ishikawa, Hisashi
    Takaki, Akinobu
    Yamamoto, Kazuhide
    HEPATOLOGY, 2014, 60 : 761A - 761A
  • [8] Polaprezinc attenuates liver fibrosis in a mouse model of non-alcoholic steatohepatitis
    Sugino, Haruko
    Kumagai, Naoki
    Watanabe, Sakiko
    Toda, Kyoko
    Takeuchi, Osamu
    Tsunematsu, Satoshi
    Morinaga, Shojiroh
    Tsuchimoto, Kanji
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 (12) : 1909 - 1916
  • [9] An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis
    Matsumoto, Masahiko
    Hada, Natsuko
    Sakamaki, Yoshiyuki
    Uno, Akiko
    Shiga, Toshihiko
    Tanaka, Chiaki
    Ito, Tsuneo
    Katsume, Asao
    Sudoh, Masayuki
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2013, 94 (02) : 93 - 103
  • [10] Sorafenib prevents liver fibrosis in a non-alcoholic steatohepatitis (NASH) rodent model
    Stefano, J. T.
    Pereira, I. V. A.
    Torres, M. M.
    Bida, P. M.
    Coelho, A. M. M.
    Xerfan, M. P.
    Cogliati, B.
    Barbeiro, D. F.
    Mazo, D. F. C.
    Kubrusly, M. S.
    D'Albuquerque, L. A. C.
    Souza, H. P.
    Carrilho, F. J.
    Oliveira, C. P.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2015, 48 (05) : 408 - 414
12345